The hungry bone syndrome - An update;Hungriger knochen nach parathyreoidektomie - Das «hungry bone syndrome»

Therapeutische Umschau

Volumn 64, Issue 5, 2007, Pages 277-280

  Farese, Stefan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; MAGNESIUM; PHOSPHATE; VITAMIN D;

AGE; ALKALINE PHOSPHATASE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CALCIUM TRANSPORT; DISEASE SEVERITY; HORMONE BLOOD LEVEL; HUMAN; HUNGRY BONE SYNDROME; HYPERPARATHYROIDISM; HYPOCALCEMIA; KIDNEY FAILURE; METABOLIC DISORDER; OSTEOBLAST; OSTEOLYSIS; PARATHYROID ADENOMA; PARATHYROIDECTOMY; REVIEW; RISK FACTOR;

ADMINISTRATION, ORAL; ADOLESCENT; ALKALINE PHOSPHATASE; BONE AND BONES; CALCIUM; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPOCALCEMIA; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; OSTEOBLASTS; OSTEOCLASTS; PARATHYROID HORMONE; PARATHYROIDECTOMY; PERITONEAL DIALYSIS; PHOSPHATES; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SYNDROME; VITAMIN D;

EID: 34250004706     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.64.5.277     Document Type: Review

References (19)

1. Bergenfelz A, Valdermarsson S, Ahren B. Functional recovery of the parathyroid glands after surgery for primary hyperparathyreoidism. Surgery 1994; 116: 827-36.
2. Brasier AR, Nussbaum SR. Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery. Am J Med 1988; 84(4): 654-60.
3. Reiser P, Wimpfheimer C. Das «hungry bone»-Syndrom: ein in Vergessenheit geratenes Krankheitsbild. Schweiz Med Wochenschr 1996; 126: 2217-22.
4. Jofre R, Gomez JM, Menarguez J, et al. Parathyreoidectomy: Whom and when? Kidney International 2003; 63 Suppl 85: 97-100.
5. Dembinski TC, Yatscoff RW, Blandford DE. Thyrotoxicosis and hungry bone syndrome-A cause of posttreatment hypocalcemia. Clin Biochem 1994; 27: 69-74.
6. Harley HAJ, Mason R, Phillips PJ. Profound hypocalcemia associated with oestrogen treatment of carcinoma of prostate. Med J Aust 1983; 2: 41-2.
7. Vogengesang SA, McMillin JM. Hypocalcemia associated with oestrogen therapy for metastatic adenocarcinoma of the prostate. J Urol 1988; 140: 1025-7.
8. Frisch LS, Mimouni F. Hypomagnesemia following correction of metabolic acidosis: a case of hungry bones. J Am Coll Nutr 1993; 12(6): 710-3.
9. Cruz DN, Perezella MA. Biochemical aberration in a dialysis patient following parathyreoidectomy. Am J Kidney Dis 1997; 29: 759.
10. Shpitz B, Korzets Z, Dinbar A, et al. Immediate postoperative management of parathyroidectomized hemodialysis patients. Dial Transplant 1986; 15: 507.
11. Benz RL, Schliefer Cr, Teehan BP, et al. Successfull treatment of postparathyreoidectomy hypocalcemia using continuous ambulatory intraperitoneal calcium therapy. Perit Dial Int 1989; 9: 285.
12. Shinoda T, Aizawa T, Shirota T, et al. Exacerbation of latent heart failure by mild hypocalcemia after parathyreoidectomy in a long-term hemodialysis patient. Nephron 1992; 60: 482.
13. Cozzolino M, Gallieni M, Corsi C, et al. Management of calcium refilling post-parathyreoidectomy in end-stage renal disease. J Nephrol 2004; 17: 3-8.
14. Clair F, Leenhardt L, Bourdeau A, et al. Effect of calcitriol in the control of plasma calcium after parathyreoidectomy. A placebo-controlled, double-blind study in chronic hemodialysis patients. Nephron 1987; 46: 18.
15. Llach F. Parathyreoidectomy in chronic renal failure: Indications, surgical approach and the use of calcitriol. Kidney Int 1990; 38 (Suppl): 62-8.
16. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and Disorders of Mineral Metabolism. In: Wilson JD, Foster DW, Kronenberg HM, et al. (Eds). Williams Textbook of Endocrinology. 9th Edn. Ohiladelphia; WB Saunders, 1998: 1155-210.
17. Serra AL, Schwarz AA, Wick FH, et al. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20(7): 1315-9.
18. Kruse AE, Eisenberger U, Frey FJ, et al. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyreoidism. Nephrol Dial Transplant 2005; 20(7): 1311-4.
19. Lee IT, Sheu WH, Tu ST, et al. Bisphosphonate pre-treatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism. J Bone Miner Metab 2006; 24: 255-8.